Polyphase wireless power transfer system achieves 270-kilowatt charge, s...
Jennifer Morrell-Falvey’s interest in visualizing the science behind natural processes was what drew her to ORNL in what she expected to be a short stint some 18 years ago.
Surrounded by the mountains of landlocked Tennessee, Oak Ridge National Laboratory’s Teri O’Meara is focused on understanding the future of the vitally important ecosystems lining the nation’s coasts.
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
As rising global temperatures alter ecosystems worldwide, the need to accurately simulate complex environmental processes under evolving conditions is more urgent than ever.
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
Scientists at ORNL and the University of Nebraska have developed an easier way to generate electrons for nanoscale imaging and sensing, providing a useful new tool for material science, bioimaging and fundamental quantum research.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.